Anaheim Bio

Series-A
anaheimbio.com Biotech & Healthcare
Total Funding $44.9M
Latest Round $44.9M Series-A
Last Announced Nov 5, 2026
Investors Undisclosed
Decision Makers Profile Active

About Anaheim Bio

Anaheim Bio is unlocking the power of small molecules to transform disease and improve patients' lives.

Sectors & Market Categories

Company Details

Intelligence Dossier

Corporate & Operational Profile

Primary Industry Biotech & Healthcare
Funding Stage Series-A
Global Headquarters Undisclosed
Tracked Since Nov 5, 2026

Web & Domain Identity

Official Website anaheimbio.com
Domain Registered Date Undisclosed

Social & Network Presence

X / Twitter Profile @companies
LinkedIn Corporate Not linked

Company Milestones & Timeline

1 Events
  1. Capital Raise

    Raised $44,900,000 · Series-A

    finsmes.com

Investors & Backers

Investor firms and individual backers were not publicly disclosed in available round filings for Anaheim Bio.

Funding History

1 Round
Series-A equity · Nov 5, 2026
$44,900,000 finsmes.com

Press Coverage & Sources

Recently Funded Biotech & Healthcare Startups

View all

Search the startup feeds free with 50 starter credits.

Recently funded startups
New SaaS launches
Never pay twice for contacts